|
Volumn 154, Issue 10, 1995, Pages 5590-5600
|
Administration of noncytolytic IL-10/Fc in murine models of lipopolysaccharide-induced septic shock and allogeneic islet transplantation
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
HYBRID PROTEIN;
IMMUNOGLOBULIN FC FRAGMENT;
INTERLEUKIN 10;
LIPOPOLYSACCHARIDE;
RECOMBINANT INTERLEUKIN 10;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY;
ARTICLE;
CELL LINE;
CONTROLLED STUDY;
CYTOLYSIS;
CYTOTOXIC T LYMPHOCYTE;
DNA SYNTHESIS;
DOSE RESPONSE;
DRUG ACTIVITY;
DRUG BLOOD LEVEL;
DRUG EFFICACY;
DRUG HALF LIFE;
GRAFT REJECTION;
HISTOLOGY;
INTRAVENOUS DRUG ADMINISTRATION;
MOUSE;
NONHUMAN;
PANCREAS ISLET TRANSPLANTATION;
PRIORITY JOURNAL;
SEPTIC SHOCK;
SITE DIRECTED MUTAGENESIS;
ANIMAL;
FEMALE;
GRAFT REJECTION;
IMMUNOGLOBULINS, FC;
INTERLEUKIN-10;
ISLETS OF LANGERHANS TRANSPLANTATION;
LIPOPOLYSACCHARIDES;
MICE;
MICE, INBRED BALB C;
MICE, INBRED C57BL;
RECOMBINANT FUSION PROTEINS;
SHOCK, SEPTIC;
SUPPORT, NON-U.S. GOV'T;
SUPPORT, U.S. GOV'T, P.H.S.;
|
EID: 0029020011
PISSN: 00221767
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (166)
|
References (0)
|